U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR® ...Middle East

OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating comparable efficacy and safety profile with the reference product XOLAIR® (omalizumab)[1] The...

Read More Details
Finally We wish PressBee provided you with enough information of ( U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR® )

Also on site :

• Brynn Whitfield Announces Exit From 'RHONY' After Two Seasons
• Pop Princess Covers Classic ‘70s Rock Hit: ‘This Is So Good’
• Born on One of These 4 Dates? You're a Wise, Old Soul